Eton Pharmaceuticals, Inc.
ETON
$16.90
-$2.24-11.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -407.34% | 15.00% | -93.83% | 73.49% | 208.29% |
| Total Depreciation and Amortization | 262.95% | 260.22% | 332.91% | 9.23% | 45.55% |
| Total Amortization of Deferred Charges | 1,164.29% | 32.20% | 1,076.00% | 4,386.96% | -135.00% |
| Total Other Non-Cash Items | 216.26% | 299.76% | 181.17% | 4.28% | 6.16% |
| Change in Net Operating Assets | 704.35% | 96.91% | 99.86% | -254.86% | 161.91% |
| Cash from Operations | 307.38% | 534.18% | 184.51% | -297.67% | 238.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -947.74% | -- |
| Cash from Investing | -- | -- | -- | -4,820.26% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | 5,528.57% | 8,980.22% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 100.00% | 204.23% | 11,519.05% | -4.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 357.42% | 666.03% | 152.48% | -680.79% | 409.33% |